Usual
DeviceAll subjects will wear their usual pouching system for the first 21 days of the study.
NCT Number: NCT00902252
The purpose of this clinical study is to demonstrate that the Vitala™ Continence Control Device is both safe and effective when worn up to 12 hours per day.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
University Hospital Freiburg, Freiburg im Breisgau, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All subjects will wear their usual pouching system for the first 21 days of the study.
All subjects will wear the Natura® Flexible Skin Barrier with Flange (Stomahesive® or Durahesive®) in the US and Natura® Stomahesive® Flexible Skin Barrier with Flange in Europe for 14 days.
After the successful completion of Stages 1 and 2, subjects will enter the "ramp up" schedule to allow the subject to adjust to the device. This consists of weekly increases in wear time of the Vitala™ device beginning with 4 hours of daily wear per week (Days 36 to 42), followed by 6 hours of daily wear time per week (Day 43 to 49), followed by 8 hours of daily wear time (Days 50 to 56) and progressing to 12 hours of daily wear per week (Day 57 to 215).
Time frame: 159 Days
Will be assessed by measuring the frequency of adverse events relating to the stoma (including gastrointestinal, stomal and surrounding skin events), microbiology profile and stomal vascularity.
Time frame: 159 days
Absence of fecal leakage around the device.
Time frame: 215 Days
Will be assessed by the following: measurement of health economic outcomes, resource use, security, wear time, comfort, control of odor, control of noise, ease of use during application and removal, subject acceptance of the device.
ConvaTec Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02861443
Colostomy
Nîmes, Gard, France
View Trial DetailsNCT06614491
Colostomy, Ileostomy
São Paulo, Brazil
View Trial DetailsNCT01207479
Colostomy
View Trial DetailsNCT02517541
Colostomy, Ileostomy - Stoma
Chicago, Illinois, United States
View Trial Details